Grants per year
Grants
- 10 Active
Search results
-
Active
Prot # A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Eicacy of TTI-101 in Participants with Idiopathic Pulmonary Fibrosis
Bemiss, B. (PD/PI)
Pharmaceutical Research Associates, Inc., Tvardi Therapeutics, Inc.
1/27/25 → 1/26/28
Project: Research project
-
Prot #AP01-007: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF
Bemiss, B. (PD/PI)
DevPro Biopharma LLC, Avalyn Pharma Inc.
9/4/24 → 9/4/27
Project: Research project
-
Prot #RIN-PF-305: A Randomized, Double-Blind, Placebo-Controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)
Bemiss, B. (PD/PI)
PPD Investigator Services, LLC, United Therapeutics Corporation
6/10/24 → 6/10/27
Project: Research project
-
Prot #GMS-PH-001: PHINDER: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection
Bemiss, B. (PD/PI)
Medpace, Inc., United Therapeutics Corporation
5/2/24 → 5/2/27
Project: Research project
-
Prot #218224: A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, ParallelGroup Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults with Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Bemiss, B. (PD/PI)
PPD Investigator Services, LLC, GlaxoSmithKline LLC
1/17/24 → 1/17/27
Project: Research project
-
Prot #RIN‐PF‐302: An Open‐label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Bemiss, B. (PD/PI) & Dematte D'Amico, J. E. (PD/PI)
United Therapeutics Corporation
8/18/23 → 8/18/26
Project: Research project
-
Prot #GB44496: A Two‐Cohort, Phase II, Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patients
Bemiss, B. (PD/PI) & Dematte D'Amico, J. E. (PD/PI)
PPD Investigator Services, LLC, Genentech, Inc
6/26/23 → 8/10/27
Project: Research project
-
Prot #RIN-PF-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Bemiss, B. (PD/PI) & Dematte D'Amico, J. E. (PD/PI)
United Therapeutics Corporation
4/28/22 → 4/30/26
Project: Research project
-
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype Prospective Outcomes (ILD-PRO) Registry
Bemiss, B. (PD/PI), Dematte D'Amico, J. E. (PD/PI) & Dematte D'Amico, J. E. (PD/PI)
Duke University, Boehringer Ingelheim Pharmaceuticals, Inc.
8/21/20 → 8/21/28
Project: Research project